Sage Therapeutics Inc Capital Reinvestment Ratio
Sage Therapeutics Inc capital reinvestment ratio. Sage Therapeutics Inc (SAGE) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($1.01 Billion) in capital expenditures ($1.00K). Check SAGE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sage Therapeutics Inc (2020–2020)
Capital reinvestment ratio of Sage Therapeutics Inc from 2020 to 2020. This chart tracks Sage Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Sage Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Sage Therapeutics Inc Capital Reinvestment Ratio by Year (2020–2020)
Sage Therapeutics Inc capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see Sage Therapeutics Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $664.28 Million | $345.00K | — |